Regina Reul

Title: Regina Reul: Innovator in Pharmaceutical Compositions

Introduction

Regina Reul is a notable inventor based in Mannheim, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of Hepatitis C Virus (HCV). Her innovative work has led to the development of a unique solid pharmaceutical composition that showcases her expertise and dedication to improving healthcare.

Latest Patents

Regina Reul holds 1 patent for her invention titled "Solid pharmaceutical compositions for treating HCV." This patent features solid pharmaceutical compositions that comprise Compound 1 and Compound 2. In one embodiment, the solid pharmaceutical composition includes a first layer comprising 100 mg of Compound 1, along with a pharmaceutically acceptable hydrophilic polymer and a pharmaceutically acceptable surfactant, all formulated in amorphous solid dispersion. Additionally, the second layer consists of 40 mg of Compound 2, also formulated with a hydrophilic polymer and surfactant in amorphous solid dispersion.

Career Highlights

Regina Reul is associated with AbbVie Inc., a leading global biopharmaceutical company. Her work at AbbVie has allowed her to focus on innovative solutions for complex health issues. Her contributions have been instrumental in advancing pharmaceutical research and development.

Collaborations

Throughout her career, Regina has collaborated with esteemed colleagues, including Nancy E Sever and Ulrich Westedt. These collaborations have fostered a productive environment for innovation and have contributed to the success of her projects.

Conclusion

Regina Reul's work in developing solid pharmaceutical compositions for treating HCV exemplifies her commitment to innovation in the pharmaceutical industry. Her contributions continue to impact the field positively, showcasing the importance of research and collaboration in advancing healthcare solutions.